PBM
Psyence Biomedical Ltd.
NASDAQ · Healthcare · Biotechnology · CA
$4.54
+2.48%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 2.78x
- PEG TTM
- —
- Price / book
- 1.46x
- Price / sales
- —
- Price / cash flow
- -2.13x
Enterprise value
- Enterprise value
- $10.1M
- EV / sales
- —
- EV / EBITDA
- -4.79x
- EV / EBIT
- -2.91x
- Market cap
- $17.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026